Seeing Is Believing
CRDL is currently covered by 1 analysts with an average price target of $4.91. This is a potential upside of $3.74 (319.66%) from yesterday's end of day stock price of $1.17.
Cardiol Therapeutics's activity chart (see below) currently has 11 price targets and 16 ratings on display. The stock rating distribution of CRDL is 100% BUY.
Highest price target for CRDL is $2, Lowest price target is $1.
Most recent stock forecast was given by VERNON BERNARDINO from HC WAINWRIGHT on 15-Apr-2025.
Currently out of the existing stock ratings of CRDL, 5 are a BUY (100%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy
6 months 13 days ago
(15-Apr-2025)
0/4 (0%)
$7.12 (378.72%)
Buy
$8
$6.81 (572.27%)
1 years 5 months 6 days ago
(22-May-2024)
0/3 (0%)
$5.77 (258.74%)
Buy
$3
$1.81 (152.10%)
$8
2 years 2 months 15 days ago
(13-Aug-2023)
0/2 (0%)
$2.07 (222.58%)
What is CRDL (Cardiol Therapeutics) average time for price targets to be met?
Which analyst has the current highest performing score on CRDL (Cardiol Therapeutics) with a proven track record?
Which analyst has the current lower performing score on CRDL (Cardiol Therapeutics) with a proven track record?
Which analyst has the most public recommendations on CRDL (Cardiol Therapeutics)?
Which analyst is the currently most bullish on CRDL (Cardiol Therapeutics)?
Which analyst is the currently most reserved on CRDL (Cardiol Therapeutics)?